NCT03639610 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- SAEs were collected from signing of the ICF until 30 days after the last dose of study treatment or initiation of subsequent therapy, whichever occurred first. Maximum treatment durations for Cohorts 1a, 1b & 2a were 127.1, 94.7 and 36.1 weeks respectively. The AE reporting period is estimated to be 30 days longer.
- Other-event reporting threshold
- 0%
Non-serious AEs were collected from the start of study treatment until 30 days after the last dose of any study drug or initiation of subsequent therapy, whichever occurred first. The median overall treatment duration for all patients was 25.57 weeks, and the duration of AE reporting is expected to be similar.
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Cohort 1a, Melflufen 40 mg | 9 / 21 | 20 / 21 | 16 / 21 |
| Cohort 1b, Melflufen 30 mg | 5 / 10 | 10 / 10 | 3 / 10 |
| Cohort 2a, Melflufen 20 mg | 0 / 4 | 3 / 4 | 1 / 4 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Catheter site haemorrhage
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Disease progression
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Sudden cardiac death
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 21
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Pneumonia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Septic shock
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Endocarditis bacterial
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Respiratory tract infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Sepsis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 21
- num Events
- 8
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Cardiac failure
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Atrial fibrillation
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 14
- num At Risk
- 21
- num Events
- 79
- group Id
- EG001
- num Affected
- 9
- num At Risk
- 10
- num Events
- 42
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 4
- num Events
- 2
- term
- Thrombocytopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 21
- num Events
- 42
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 10
- num Events
- 17
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 21
- num Events
- 31
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 10
- num Events
- 14
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 21
- num Events
- 5
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 10
- num Events
- 4
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Leukopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 21
- num Events
- 4
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- term
- Diarrhoea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 21
- num Events
- 5
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- term
- Vomiting
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 2
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 10
- num Events
- 6
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Oesophagitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Toothache
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 21
- num Events
- 6
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 21
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Asthenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 10
- num Events
- 2
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- term
- Pyrexia
Complete source fields
- description
- Non-serious AEs were collected from the start of study treatment until 30 days after the last dose of any study drug or initiation of subsequent therapy, whichever occurred first. The median overall treatment duration for all patients was 25.57 weeks, and the duration of AE reporting is expected to be similar.
- event Groups
- deaths Num Affected
- 16
- deaths Num At Risk
- 21
- description
- Patients with moderate renal impairment (eGFR ≥30 to \<45 mL/min/1.73m²) and a starting dose of melflufen of 40 mg.
- id
- EG000
- other Num Affected
- 20
- other Num At Risk
- 21
- serious Num Affected
- 9
- serious Num At Risk
- 21
- title
- Cohort 1a, Melflufen 40 mg
- deaths Num Affected
- 3
- deaths Num At Risk
- 10
- description
- Patients with moderate renal impairment (eGFR ≥30 to \<45 mL/min/1.73m²) and a starting dose of melflufen of 30 mg.
- id
- EG001
- other Num Affected
- 10
- other Num At Risk
- 10
- serious Num Affected
- 5
- serious Num At Risk
- 10
- title
- Cohort 1b, Melflufen 30 mg
- deaths Num Affected
- 1
- deaths Num At Risk
- 4
- description
- Patients with severe renal impairment (eGFR ≥15 to \<30 mL/min/1.73m²) and a starting dose of melflufen of 20 mg.
- id
- EG002
- other Num Affected
- 3
- other Num At Risk
- 4
- serious Num Affected
- 0
- serious Num At Risk
- 4
- title
- Cohort 2a, Melflufen 20 mg
- frequency Threshold
- 0
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 14
- num At Risk
- 21
- num Events
- 79
- group Id
- EG001
- num Affected
- 9
- num At Risk
- 10
- num Events
- 42
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 4
- num Events
- 2
- term
- Thrombocytopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 21
- num Events
- 42
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 10
- num Events
- 17
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 21
- num Events
- 31
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 10
- num Events
- 14
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 21
- num Events
- 5
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 10
- num Events
- 4
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Leukopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 21
- num Events
- 4
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- term
- Diarrhoea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 21
- num Events
- 5
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- term
- Vomiting
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 2
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 10
- num Events
- 6
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Oesophagitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Toothache
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 21
- num Events
- 6
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 21
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Asthenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 10
- num Events
- 2
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- term
- Pyrexia
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Catheter site haemorrhage
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Disease progression
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Sudden cardiac death
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 21
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Pneumonia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Septic shock
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Endocarditis bacterial
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Respiratory tract infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 21
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Sepsis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 21
- num Events
- 8
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Cardiac failure
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA version 24.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 21
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- term
- Atrial fibrillation
- time Frame
- SAEs were collected from signing of the ICF until 30 days after the last dose of study treatment or initiation of subsequent therapy, whichever occurred first. Maximum treatment durations for Cohorts 1a, 1b & 2a were 127.1, 94.7 and 36.1 weeks respectively. The AE reporting period is estimated to be 30 days longer.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle